DANVITAL ApS: Financial statements 2016
CVR: 34595062
DANVITAL ApS (CVR 34595062) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -14,117 and a net result of DKK -8,742 compared with DKK -10,552 the year before. Equity amounted to DKK 51,046. The solvency ratio was 90.4%.
- Gross Profit
- -14,117 kr.
- Profit/Loss
- -8,742 kr.
- Equity
- 51,046 kr.
- Total Assets
- 56,470 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -14 t. | -9 t. | 51 t. | - |
| 2015 | - | -17 t. | -11 t. | 60 t. | - |
| 2014 | - | 8 t. | 9 t. | 70 t. | - |
| 2013 | - | -29 t. | -19 t. | 61 t. | - |
How creditworthy is DANVITAL ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
DANVITAL ApS has published its annual report for 2015. Gross profit came to DKK -16,835, and the net result was DKK -10,552.
About DANVITAL ApS
DANVITAL ApS was a Danish company of the type Anpartsselskab based in Svendborg, founded in 2012 and dissolved in 2022. The company was registered under the industry Fremstilling af farmaceutiske præparater. In 2020, the company reported a gross profit of DKK -19,790 and a net result of DKK -19,803 compared with DKK -32,749 the year before. Equity amounted to DKK -43,202.
